Asia Business News | Sunday, May 18, 2008
email news alerts
RSS 2.0  
Tissue Therapies Limited is an Australian company developing biomedical technologies for wound healing, tissue and various cell culture applications.

The Company has worldwide exclusive rights to commercialise VitroGro, a platform technology developed by tissue engineering experts at the Institute for Health and Biomedical Innovation at QUT for enhancing cell growth and migration. VitroGro has particular commercial applications in wound healing, tissue regeneration, stem cell therapies and other cell culture uses.

Based on its VitroGro platform technology, Tissue Therapies is developing more effective medical treatments for wounds and burns, integration of orthopaedic and medical implants, and other applications such as cosmeceuticals.

Tissue Therapies also provides cell culture reagents to enhance the growth of mammalian cells for emerging cell-based therapies, along with research and industrial cell culture markets internationally.

More information: www.tissuetherapies.com
Company Fax (07) 3220 1482 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Listed 2004/03/19 
Company Homepage www.tissuetherapies.com
 
Stock Exchange Stock Code
ASXTIS
News Reader RSS   TISSUE THERAPIES LIMITED
 Ethics Approval Granted For Tissue Therapies Limited's (ASX: TIS) VitroGro Human Clinical Trial (FEB 7, 2008)
Drag Podcast Icon To iTunes - Podcast Download for TISSUE THERAPIES LIMITED
 TISSUE THERAPIES LIMITED ASX: TIS - Small Caps Forum
Interview with Dr Stephen Mercer, CEO
(MAR 27, 2006)